SELLAS Life Sciences Group, Inc. - Common Stock (SLS)
CUSIP: 81642T209
Q4 2023 13F Holders as of 31 Dec 2023
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 178,475,456
- Total 13F shares
- 3,493,044
- Share change
- +741,366
- Total reported value
- $3,702,505
- Put/Call ratio
- 2.2%
- Price per share
- $1.06
- Number of holders
- 29
- Value change
- +$352,826
- Number of buys
- 18
- Number of sells
- 9
Quarterly Holders Quick Answers
What is CUSIP 81642T209?
CUSIP 81642T209 identifies SLS - SELLAS Life Sciences Group, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 81642T209:
Top shareholders of SLS - SELLAS Life Sciences Group, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
0.58%
|
1,036,906
|
$1,700,526 | — | 30 Sep 2023 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.36%
|
640,011
|
$1,049,618 | — | 30 Sep 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.16%
|
280,596
|
$460,177 | — | 30 Sep 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.13%
|
235,603
|
$386,510 | — | 30 Sep 2023 | |
| Equitable Holdings, Inc. |
13F
|
Company |
0.08%
|
135,000
|
$221,400 | — | 30 Sep 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.05%
|
97,129
|
$159,292 | — | 30 Sep 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.04%
|
70,446
|
$115,531 | — | 30 Sep 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.02%
|
39,360
|
$64,550 | — | 30 Sep 2023 | |
| Opus Capital Group, LLC |
13F
|
Company |
0.02%
|
34,500
|
$57,000 | — | 30 Sep 2023 | |
| XTX Topco Ltd |
13F
|
Company |
0.02%
|
32,982
|
$54,090 | — | 30 Sep 2023 | |
| Prosperity Financial Group, Inc. |
13F
|
Company |
0.01%
|
24,800
|
$40,672 | — | 30 Sep 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.01%
|
20,414
|
$33,479 | — | 30 Sep 2023 | |
| Virtu Financial LLC |
13F
|
Company |
0.01%
|
18,962
|
$31,000 | — | 30 Sep 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
16,317
|
$26,759 | — | 30 Sep 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.01%
|
16,238
|
$26,630 | — | 30 Sep 2023 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.01%
|
12,414
|
$20,000 | — | 30 Sep 2023 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.01%
|
11,032
|
$18,092 | — | 30 Sep 2023 | |
| Nemes Rush Group LLC |
13F
|
Company |
0.01%
|
10,000
|
$16,400 | — | 30 Sep 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
9,014
|
$14,783 | — | 30 Sep 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
4,034
|
$6,616 | — | 30 Sep 2023 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
3,320
|
$5,444 | — | 30 Sep 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
2,420
|
$3,969 | — | 30 Sep 2023 | |
| Allworth Financial LP |
13F
|
Company |
0%
|
150
|
$246 | — | 30 Sep 2023 | |
| UBS Group AG |
13F
|
Company |
0%
|
26
|
$43 | — | 30 Sep 2023 | |
| Parkside Financial Bank & Trust |
13F
|
Company |
0%
|
2
|
$4 | — | 30 Sep 2023 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0%
|
2
|
$3 | — | 30 Sep 2023 |
Institutional Holders of SELLAS Life Sciences Group, Inc. - Common Stock (SLS) as of Q4 2023
As of 31 Dec 2023,
SELLAS Life Sciences Group, Inc. - Common Stock (SLS) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,493,044 shares.
The largest 10 holders included
VANGUARD GROUP INC, ARMISTICE CAPITAL, LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, GROUP ONE TRADING, L.P., Equitable Holdings, Inc., Opus Capital Group, LLC, STATE STREET CORP, Bank of New York Mellon Corp, and NORTHERN TRUST CORP.
This page lists
29
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
25
Q4 2023 holders
29
Holder diff
4
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 Value $ | Q4 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.